Mounteney J - Search Results

1

Reducing drug related mortality in Europe - a seemingly intractable public health issue.

Giraudon I, Vicente J, Matias J, Mounteney J, Griffiths P. Giraudon I, et al. Among authors: mounteney j. Adicciones. 2012;24(1):3-7. Adicciones. 2012. PMID: 22508011 Free article.

2

The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015.

Mounteney J, Griffiths P, Sedefov R, Noor A, Vicente J, Simon R. Mounteney J, et al. Addiction. 2016 Jan;111(1):34-48. doi: 10.1111/add.13056. Epub 2015 Sep 30. Addiction. 2016. PMID: 26419329 Review.

3

Fentanyls: Are we missing the signs? Highly potent and on the rise in Europe.

Mounteney J, Giraudon I, Denissov G, Griffiths P. Mounteney J, et al. Int J Drug Policy. 2015 Jul;26(7):626-31. doi: 10.1016/j.drugpo.2015.04.003. Epub 2015 Apr 17. Int J Drug Policy. 2015. PMID: 25976511

4

New psychoactive substances: Current health-related practices and challenges in responding to use and harms in Europe.

Pirona A, Bo A, Hedrich D, Ferri M, van Gelder N, Giraudon I, Montanari L, Simon R, Mounteney J. Pirona A, et al. Among authors: mounteney j. Int J Drug Policy. 2017 Feb;40:84-92. doi: 10.1016/j.drugpo.2016.10.004. Epub 2016 Dec 9. Int J Drug Policy. 2017. PMID: 27956184

5

Is Europe facing an opioid epidemic: What does European monitoring data tell us?

Seyler T, Giraudon I, Noor A, Mounteney J, Griffiths P. Seyler T, et al. Among authors: mounteney j. Eur J Pain. 2021 May;25(5):1072-1080. doi: 10.1002/ejp.1728. Epub 2021 Feb 2. Eur J Pain. 2021. PMID: 33428812

6

Nine reasons why ecstasy is not quite what it used to be.

Mounteney J, Griffiths P, Bo A, Cunningham A, Matias J, Pirona A. Mounteney J, et al. Int J Drug Policy. 2018 Jan;51:36-41. doi: 10.1016/j.drugpo.2017.09.016. Epub 2017 Nov 20. Int J Drug Policy. 2018. PMID: 29156401

7

The Experience of the Treatment Demand Indicator in Europe: A Common Monitoring Tool Across 30 Countries.

Montanari L, Pirona A, Guarita B, Hedrich D, Mounteney J, Vicente J. Montanari L, et al. Among authors: mounteney j. J Stud Alcohol Drugs Suppl. 2019 Jan;Sup 18:139-151. doi: 10.15288/jsads.2019.s18.139. J Stud Alcohol Drugs Suppl. 2019. PMID: 30681958 Free PMC article.

8

The impact of the COVID-19 lockdown on drug service provision in European prisons.

Montanari L, Teltzrow R, Vanmalderen S, Ranieri R, Martín Peláez JA, Vandam L, Mounteney J, Pirona A, Meroueh F, Giraudon I, Matias J, Skarupova K, Royuela L, Morel d'Arleux J. Montanari L, et al. Among authors: mounteney j. Int J Prison Health. 2021 Aug 21. doi: 10.1108/IJPH-11-2020-0089. Online ahead of print. Int J Prison Health. 2021. PMID: 34410050

9

Addiction research centres and the nurturing of creativity. Monitoring the European drug situation: the ongoing challenge for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).

Griffiths P, Mounteney J, Lopez D, Zobel F, Götz W. Griffiths P, et al. Among authors: mounteney j. Addiction. 2012 Feb;107(2):254-8. doi: 10.1111/j.1360-0443.2011.03369.x. Epub 2011 May 3. Addiction. 2012. PMID: 21539630

10

Trends in MDMA-related mortality across four countries.

Roxburgh A, Sam B, Kriikku P, Mounteney J, Castanera A, Dias M, Giraudon I. Roxburgh A, et al. Among authors: mounteney j. Addiction. 2021 Nov;116(11):3094-3103. doi: 10.1111/add.15493. Epub 2021 Apr 15. Addiction. 2021. PMID: 33739562

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page